Study of a new medical device to treat brain aneurysms

Nautilus endovascular device for wide neck cerebral aneurysm embolization study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN96627183

Enrollment

100

Registered

2020-01-16

Start date

2022-09-01

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral aneurysm Circulatory System Cerebral aneurysm, nonruptured

Interventions

Patients will undergo a single intervention with the Nautilus Endovascular Device followed by treatment follow up at 6 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who present with intracranial aneurysm

Exclusion criteria

Exclusion criteria: Unstable neurological deficit

Design outcomes

Primary

Measure	Time frame
Death or stroke in treated vascular territory measured using the NIH stroke scale at intervention and at 6 months follow-up	—

Secondary

Measure	Time frame
Rate of stable, successful aneurysm occlusion measured using the Raymond Roy Occlusion Classification at intervention and at 6 months follow-up	—

Countries

Brazil

Contacts

Public ContactDanel Mayer

danel@endostream.com+972 (0)4 842 4810

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 1, 2026